Atezolizumab, sold under the brand name Tecentriq among others, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma and alveolar soft part sarcoma, but discontinued for use in triple-negative breast cancer. From Wikipedia
